Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.49101.47-45.3620.0567.42

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is 11.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202511.49
Mar2024101.47
Mar2023-45.36
Mar202220.05
Mar202167.42

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 11.49
-88.68
Mar2024 101.47
Positive
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,409.0 Cr 3% 5.4% -33.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,610.0 Cr -2.1% 13.6% 6.3% Stock Analytics
DIVIS LABORATORIES ₹179,279.0 Cr -2% 6.2% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,649.0 Cr 0.5% 8.2% 39% Stock Analytics
CIPLA ₹114,469.0 Cr 1.3% 9.5% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,955.0 Cr 0.6% 1% 8.8% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

3%

5.4%

-33.7%

SENSEX

1.1%

-2.1%

-6.4%


You may also like the below Video Courses